Trial Profile
An open label, randomised, two-period crossover study investigating pharmacokinetics of ticagrelor with and without aspirin in healthy volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Acute coronary syndromes; Thromboembolism
- Focus Pharmacokinetics
- 28 Dec 2015 New trial record